Dr. Bradley Quon, a Principal Investigator with the Centre for Heart Lung Innovation (HLI), medical and research director of the Cystic Fibrosis Adult Care Program at St. Paul’s Hospital, and an associate professor in the Department of Medicine at the University of British Columbia (UBC).
Dr. Quon’s research is dedicated to developing better tools to diagnose and monitor cystic fibrosis (CF), a genetic disorder that impacts respiratory, digestive, and reproductive health. His work spans biomarker research, epidemiological research, and clinical trials.
He studied medicine at McGill University, completed an internal medicine residency and a respirology fellowship at UBC, and received a Master’s of Science in Epidemiology and Biostatistics at the University of Washington. He served as the inaugural medical director for Cystic Fibrosis Canada’s clinical trials network, CanACT, a program that aims to engage CF patients in clinical trials and increase research capacity.
“Dr. Quon is an exceptional clinician-scientist, who over his career has improved the lives of patients living with cystic fibrosis through his cutting-edge research program, clinical care and tireless advocacy. He is an even better person – caring, compassionate and diligent,” says Dr. Don Sin, Director of the HLI.